UnitedHealth Group Incorporated (UNH)
499.72 USD +14.20 (+2.92%) Volume: 10.0M
UnitedHealth Group Incorporated’s stock price surged to $499.72, marking a positive change of +2.92% this trading session with a trading volume of 10.0M, despite a year-to-date percentage change of -5.08%, showcasing its potential for investors in the healthcare sector.
Latest developments on UnitedHealth Group Incorporated
UnitedHealth Group has been facing a series of challenges recently, from a health data breach lawsuit in Nebraska to negative stock movements down 15.9% in the past three months. The company’s CEO, Andrew Witty, addressed backlash against the insurer, while the acquisition of OrthoAlliance showcased growing consolidation in the healthcare industry. Despite a $69 million settlement over low-performing retirement plans and attempts to stop the sale of Luigi Mangione merchandise, UnitedHealth’s stock price saw a 3% increase. However, concerns over Medicare for All and the company’s unchecked growth have also been highlighted, indicating potential trouble ahead. With ongoing controversies and legal battles, investors are closely monitoring UnitedHealth Group’s stock outlook amidst a volatile market.
UnitedHealth Group Incorporated on Smartkarma
Analyst Joe Jasper from Smartkarma has upgraded his coverage on UnitedHealth Group to Market Weight, citing new risk-off signals that suggest a pullback in the S&P 500 and QQQ. Jasper is looking for potential pullback zones between 5100-5191 on the S&P 500 and $443-$449 on the QQQ. He notes that the Russell 2000 small-caps and the Dow remain bullish, while the S&P 500 and Nasdaq 100 are experiencing a pullback/consolidation phase. Jasper expects the trend of small-cap outperformance to continue for months or longer, as the Russell 2000 vs. S&P 500 ratio reverses a 3.5-year downtrend.
A look at UnitedHealth Group Incorporated Smart Scores
Factor | Score | Magnitude |
---|---|---|
Value | 3 | |
Dividend | 4 | |
Growth | 3 | |
Resilience | 3 | |
Momentum | 3 | |
OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
UnitedHealth Group has received a positive overall outlook based on the Smartkarma Smart Scores. With a strong score of 4 for Dividend, investors can expect a reliable and consistent return on their investment. Additionally, the company scored well in Growth, Resilience, and Momentum, all with a score of 3, indicating a stable and growing business model. While the Value score is slightly lower at 3, UnitedHealth Group still presents a solid investment opportunity for those looking for long-term growth and stability in the healthcare sector.
UnitedHealth Group Incorporated, a company that owns and manages organized health systems, is positioned well for the future according to the Smartkarma Smart Scores. With a focus on providing employers with products and resources for employee benefit programs, UnitedHealth serves customers globally. The company’s strong scores across various factors such as Dividend, Growth, Resilience, and Momentum reflect its stability and potential for continued success in the healthcare industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars